Quick Takeaways
- JOHNSON & JOHNSON has 4 issuer positions tracked on this page.
- Estimated disclosed ownership value: $4,302,437,327.
- Recent insider filing activity is available below.
- Info
- Portfolio
- Significant Ownership
- Insider Ownership
- Insider Trading
- Financials
- Holders
Insider Trading & Ownership of JOHNSON & JOHNSON
- Location
- New Brunswick, NJ
- Summary
- The estimated value of insider holdings of JOHNSON & JOHNSON is at least $4,302,437,327 dollars as of 01 Dec 2025. JOHNSON & JOHNSON is the 10%+ Owner of Kenvue Inc. and owns shares of Kenvue Inc. (KVUE) stock worth about $4.19B. JOHNSON & JOHNSON is the 10%+ Owner of MeiraGTx Holdings plc and owns shares of MeiraGTx Holdings plc (MGTX) stock worth about $42.24M. JOHNSON & JOHNSON is the 10%+ Owner of CVRx, Inc. and owns shares of CVRx, Inc. (CVRX) stock worth about $40.37M. JOHNSON & JOHNSON is the 10%+ Owner of Contineum Therapeutics, Inc. and owns shares of Contineum Therapeutics, Inc. (CTNM) stock worth about $33.74M.
- Signature
- Johnson & Johnson By /s/ Marc Larkins, Secretary
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow JOHNSON & JOHNSON and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
What Changed
- Largest disclosed position: Kenvue Inc. ($4,186,085,905).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Official SEC Source
Filed on Form 4
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original FilingOwnership of JOHNSON & JOHNSON
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| KVUE | Kenvue Inc. | 10%+ Owner | $4,186,085,905 | 23 Aug 2023 | ||
| MGTX | MeiraGTx Holdings plc | 10%+ Owner | $42,237,167 | 09 Nov 2022 | ||
| CVRX | CVRx, Inc. | 10%+ Owner | $40,369,355 | -$861,042 | -2.1% | 26 Nov 2025 |
| CTNM | Contineum Therapeutics, Inc. | 10%+ Owner | $33,744,900 | 09 Apr 2024 |
Insider Transactions Reported by JOHNSON & JOHNSON:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.